130 related articles for article (PubMed ID: 36847011)
1. Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease.
Acosta-Baena N; Lopera-Gómez CM; Jaramillo-Elorza MC; Velilla-Jiménez L; Villegas-Lanau CA; Sepúlveda-Falla D; Arcos-Burgos M; Lopera F
J Alzheimers Dis; 2023; 92(3):911-923. PubMed ID: 36847011
[TBL] [Abstract][Full Text] [Related]
2. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study.
Acosta-Baena N; Sepulveda-Falla D; Lopera-Gómez CM; Jaramillo-Elorza MC; Moreno S; Aguirre-Acevedo DC; Saldarriaga A; Lopera F
Lancet Neurol; 2011 Mar; 10(3):213-20. PubMed ID: 21296022
[TBL] [Abstract][Full Text] [Related]
3. Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study.
Van der Mussele S; Fransen E; Struyfs H; Luyckx J; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
J Alzheimers Dis; 2014; 42(4):1239-50. PubMed ID: 25024328
[TBL] [Abstract][Full Text] [Related]
4. Gender, apolipoprotein E genotype, and mesial temporal atrophy: 2-year follow-up in patients with stable mild cognitive impairment and with progression from mild cognitive impairment to Alzheimer's disease.
Spampinato MV; Langdon BR; Patrick KE; Parker RO; Collins H; Pravata' E;
Neuroradiology; 2016 Nov; 58(11):1143-1151. PubMed ID: 27590747
[TBL] [Abstract][Full Text] [Related]
5.
Quiroz YT; Aguillon D; Aguirre-Acevedo DC; Vasquez D; Zuluaga Y; Baena AY; Madrigal L; Hincapié L; Sanchez JS; Langella S; Posada-Duque R; Littau JL; Villalba-Moreno ND; Vila-Castelar C; Ramirez Gomez L; Garcia G; Kaplan E; Rassi Vargas S; Ossa JA; Valderrama-Carmona P; Perez-Corredor P; Krasemann S; Glatzel M; Kosik KS; Johnson K; Sperling RA; Reiman EM; Sepulveda-Falla D; Lopera F; Arboleda-Velasquez JF
N Engl J Med; 2024 Jun; 390(23):2156-2164. PubMed ID: 38899694
[TBL] [Abstract][Full Text] [Related]
6. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.
Fleisher AS; Chen K; Quiroz YT; Jakimovich LJ; Gomez MG; Langois CM; Langbaum JB; Ayutyanont N; Roontiva A; Thiyyagura P; Lee W; Mo H; Lopez L; Moreno S; Acosta-Baena N; Giraldo M; Garcia G; Reiman RA; Huentelman MJ; Kosik KS; Tariot PN; Lopera F; Reiman EM
Lancet Neurol; 2012 Dec; 11(12):1057-65. PubMed ID: 23137949
[TBL] [Abstract][Full Text] [Related]
7. Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study.
Vila-Castelar C; Guzmán-Vélez E; Pardilla-Delgado E; Buckley RF; Bocanegra Y; Baena A; Fox-Fuller JT; Tirado V; Muñoz C; Giraldo M; Acosta-Baena N; Rios-Romenets S; Langbaum JB; Tariot PN; Lopera F; Reiman EM; Quiroz YT
J Alzheimers Dis; 2020; 77(4):1743-1753. PubMed ID: 32925067
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
[TBL] [Abstract][Full Text] [Related]
9. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
[TBL] [Abstract][Full Text] [Related]
10. Depressive symptoms and hippocampal volume in autosomal dominant Alzheimer's disease.
Langella S; Lopera F; Baena A; Fox-Fuller JT; Munera D; Martinez JE; Giudicessi A; Vannini P; Hanseeuw BJ; Marshall GA; Quiroz YT; Gatchel JR
Alzheimers Dement; 2024 Feb; 20(2):986-994. PubMed ID: 37837524
[TBL] [Abstract][Full Text] [Related]
11. Impact of Depressive Symptoms on Conversion from Mild Cognitive Impairment Subtypes to Alzheimer's Disease: A Community-Based Longitudinal Study.
Kida J; Nemoto K; Ikejima C; Bun S; Kakuma T; Mizukami K; Asada T
J Alzheimers Dis; 2016; 51(2):405-15. PubMed ID: 26890740
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease: A Retrospective Cohort Study.
Aguirre-Acevedo DC; Lopera F; Henao E; Tirado V; Muñoz C; Giraldo M; Bangdiwala SI; Reiman EM; Tariot PN; Langbaum JB; Quiroz YT; Jaimes F
JAMA Neurol; 2016 Apr; 73(4):431-8. PubMed ID: 26902171
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
14. The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
Ayutyanont N; Langbaum JB; Hendrix SB; Chen K; Fleisher AS; Friesenhahn M; Ward M; Aguirre C; Acosta-Baena N; Madrigal L; Muñoz C; Tirado V; Moreno S; Tariot PN; Lopera F; Reiman EM
J Clin Psychiatry; 2014 Jun; 75(6):652-60. PubMed ID: 24816373
[TBL] [Abstract][Full Text] [Related]
15. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
Chen XR; Shao Y; Sadowski MJ;
J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal cognitive decline in autosomal-dominant Alzheimer's disease varies with mutations in APP and PSEN1 genes.
Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Nordberg A; Viitanen M; Lannfelt L; Graff C
Neurobiol Aging; 2019 Oct; 82():40-47. PubMed ID: 31386938
[TBL] [Abstract][Full Text] [Related]
17. APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.
Vélez JI; Lopera F; Sepulveda-Falla D; Patel HR; Johar AS; Chuah A; Tobón C; Rivera D; Villegas A; Cai Y; Peng K; Arkell R; Castellanos FX; Andrews SJ; Silva Lara MF; Creagh PK; Easteal S; de Leon J; Wong ML; Licinio J; Mastronardi CA; Arcos-Burgos M
Mol Psychiatry; 2016 Jul; 21(7):916-24. PubMed ID: 26619808
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
[TBL] [Abstract][Full Text] [Related]
19. Effects of race, baseline cognition, and APOE on the association of affective dysregulation with incident dementia: A longitudinal study of dementia-free older adults.
Ebrahim IM; Ghahremani M; Camicioli R; Smith EE; Ismail Z
J Affect Disord; 2023 Jul; 332():9-18. PubMed ID: 36997127
[TBL] [Abstract][Full Text] [Related]
20. APOE ε4 influences cognitive decline positively in APP and negatively in PSEN1 mutation carriers with autosomal-dominant Alzheimer's disease.
Almkvist O; Johansson C; Laffita-Mesa J; Thordardottir S; Graff C
Eur J Neurol; 2022 Dec; 29(12):3580-3589. PubMed ID: 36039401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
